mitomycin has been researched along with Idiopathic Parkinson Disease in 1 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiller, BM | 1 |
| Marmion, DJ | 1 |
| Gross, RM | 1 |
| Thompson, CA | 1 |
| Chavez, CA | 1 |
| Brundin, P | 1 |
| Wakeman, DR | 1 |
| McMahon, CW | 1 |
| Kordower, JH | 1 |
1 other study available for mitomycin and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Mitomycin-C treatment during differentiation of induced pluripotent stem cell-derived dopamine neurons reduces proliferation without compromising survival or function in vivo.
Topics: Animals; Cell Differentiation; Cell Proliferation; Dopaminergic Neurons; Humans; Induced Pluripotent | 2021 |